Principal Investigators
Mark Brockman, Ph.D.
Professor, Molecular Biology and Biochemistry
Professor, Faculty of Health Sciences
Associate Dean Research, Faculty of Health Sciences
Email: mark_brockman@sfu.ca
Tel: 1-778-782-3341
Dr. Mark Brockman received his PhD in Virology from Harvard University in 2001. He completed postdoctoral training at Harvard Medical School and the Massachusetts General Hospital. In 2007, he was appointed as Instructor in Medicine at Harvard Medical School. Dr. Brockman arrived at 51社区黑料in September 2009 as Associate Professor in the Department of Molecular Biology and Biochemistry. He joined the Faculty of Health Sciences in September 2011. Since September 2025, he is also serving as the Associate Dean Research, Faculty of Health Sciences.
The Brockman laboratory uses molecular and cellular biology approaches to investigate questions at the interface of virology, pathogenesis, and the host immune response to human immunodeficiency virus (HIV). The laboratory has developed in vitro strategies to examine HIV protein function and host T cell activity, allowing unique population-level analyses that may assist in the development of a vaccine against HIV. Current research focuses on measuring the ability of T cell receptors (TCR) to recognize infected cell targets; and assessing the role of extracellular vesicles (EVs) on HIV pathogenesis, including the reservoir.
Zabrina Brumme, Ph.D.
Professor, Faculty of Health Sciences
Laboratory Director, British Columbia Centre for Excellence in HIV/AIDS
Email: zbrumme@sfu.ca
Tel: 1-778-782-8872
Dr. Zabrina Brumme received her PhD in Experimental Medicine from the University of British Columbia. She then completed a post-doctoral fellowship at the Ragon Institute of Massachusetts General Hospital, MIT and Harvard University in Boston. Dr. Brumme joined SFU's Faculty of Health Sciences in 2009, and is currently a full Professor. Since 2018, she is also appointed the Laboratory Director at the British Columbia Centre for Excellence in HIV/AIDS.
Dr. Brumme鈥檚 research programme integrates molecular biology, epidemiology and computational approaches to study HIV genetic diversity and evolution with the goal of informing HIV vaccine and eradication strategies. More recently her laboratory has focused on the characterization of the genetics and dynamics of the latent HIV reservoir towards the design of personalized immunotherapeutic strategies for HIV remission and cure.